Stephens Inc Dexcom Inc Transaction History

Stephens Inc

$7.43 Billion
Q3 2025

A detailed history of Stephens Inc transactions in Dexcom Inc stock. As of the latest transaction made, Stephens Inc holds 20,798 shares of DXCM stock, worth $1.47 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

20,798

Previous 23,688 12.2%

Holding current value

$1.47 Million

Previous $2.07 Million 32.32%

% of portfolio

0.02%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	SELL	$66.46 - $89.53 $192,069 - $258,741	-2,890 Reduced 12.2%	20,798 $1.4 Million
Q2 2025 Jul 29, 2025	BUY	$59.83 - $87.57 $116,189 - $170,060	1,942 Added 8.93%	23,688 $2.07 Million
Q1 2025 May 01, 2025	BUY	$67.74 - $90.75 $26,554 - $35,574	392 Added 1.84%	21,746 $1.49 Million
Q4 2024 Jan 28, 2025	SELL	$65.68 - $81.01 $105,350 - $129,940	-1,604 Reduced 6.99%	21,354 $1.66 Million
Q3 2024 Oct 28, 2024	BUY	$64.0 - $116.06 $78,080 - $141,593	1,220 Added 5.61%	22,958 $1.54 Million
Q2 2024 Aug 06, 2024	SELL	$110.31 - $140.45 $190,946 - $243,118	-1,731 Reduced 7.38%	21,738 $2.46 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $87,949 - $107,877	770 Added 3.39%	23,469 $3.26 Million
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $630,190 - $1.04 Million	-8,348 Reduced 26.89%	22,699 $2.82 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $1.05 Million - $1.68 Million	-12,185 Reduced 28.19%	31,047 $2.9 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $2.42 Million - $2.82 Million	21,538 Added 99.28%	43,232 $5.56 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $59,072 - $69,818	-568 Reduced 2.55%	21,694 $2.52 Million
Q4 2022 Jan 25, 2023	SELL	$84.98 - $122.67 $97,896 - $141,315	-1,152 Reduced 4.92%	22,262 $2.52 Million
Q3 2022 Nov 02, 2022	BUY	$76.35 - $94.18 $118,800 - $146,544	1,556 Added 7.12%	23,414 $1.89 Million
Q2 2022 Aug 03, 2022	BUY	$67.99 - $132.89 $1.11 Million - $2.17 Million	16,319 Added 294.62%	21,858 $1.63 Million
Q1 2022 May 04, 2022	BUY	$94.08 - $130.2 $22,108 - $30,596	235 Added 4.43%	5,539 $2.83 Million
Q4 2021 Mar 07, 2022	BUY	$129.87 - $162.82 $6,753 - $8,466	52 Added 0.99%	5,304 $2.85 Million
Q3 2021 Oct 27, 2021	BUY	$106.71 - $143.18 $4,588 - $6,156	43 Added 0.83%	5,252 $2.87 Million
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $103,505 - $137,934	1,278 Added 32.51%	5,209 $2.22 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $30,185 - $37,287	356 Added 9.96%	3,931 $1.41 Million
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $119,808 - $160,512	1,536 Added 75.33%	3,575 $1.32 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $39,827 - $47,100	417 Added 25.71%	2,039 $841,000
Q2 2020 Aug 24, 2020	SELL	$62.68 - $105.34 $29,334 - $49,299	-468 Reduced 22.39%	1,622 $658,000
Q1 2020 May 14, 2020	SELL	$47.79 - $75.63 $12,043 - $19,058	-252 Reduced 10.76%	2,090 $563,000
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $70,090 - $109,653	-1,914 Reduced 44.97%	2,342 $512,000
Q3 2019 Oct 18, 2019	SELL	$35.53 - $43.8 $21,886 - $26,980	-616 Reduced 12.64%	4,256 $635,000
Q2 2019 Aug 01, 2019	BUY	$27.84 - $38.92 $9,187 - $12,843	330 Added 7.27%	4,872 $730,000
Q1 2019 May 03, 2019	SELL	$28.07 - $38.18 $6,091 - $8,285	-217 Reduced 4.56%	4,542 $541,000
Q4 2018 Feb 11, 2019	SELL	$26.99 - $37.37 $8,960 - $12,406	-332 Reduced 6.52%	4,759 $570,000
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $118,874 - $186,941	5,091 New	5,091 $728,000
Q3 2017 Nov 08, 2017	SELL	$11.36 - $18.98 $81,053 - $135,422	-7,135 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	7,135	7,135 $522,000

Others Institutions Holding DXCM

# of Institutions

1,111

Shares Held

369M

Call Options Held

5.36M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $27.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account